Inhibition of drug-resistant HIV-1 by RNA interference

Antiviral Research

Volumn 69, Issue 1, 2006, Pages 1-8

  Huelsmann, Peter M ^a   Rauch, Pia ^a   Allers, Kristina ^a   John, Matthias J ^b   Metzner, Karin J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b ALNYLAM PHARMACEUTICALS   (United States)

Author keywords

Drug resistance; HIV 1; Lamivudine; M184V; RNA interference

Indexed keywords

LAMIVUDINE; SMALL INTERFERING RNA;

ANTIBIOTIC RESISTANCE; CODON; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENTIATION; DRUG TARGETING; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MIXED INFECTION; MOLECULAR RECOGNITION; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA GENE; RNA INTERFERENCE; VIRUS GENE; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; WILD TYPE;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, VIRAL; HELA CELLS; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LAMIVUDINE; MUTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 29044449691     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.10.001     Document Type: Conference Paper

References (31)

1. M. Amarzguioui, T. Holen, E. Babaie, and H. Prydz Tolerance for mutations and chemical modifications in a siRNA Nucleic Acids Res. 31 2003 589 595
2. N.K. Back, M. Nijhuis, W. Keulen, C.A. Boucher, B.O. Oude Essink, A.B. van Kuilenburg, A.H. van Gennip, and B. Berkhout Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme EMBO J. 15 1996 4040 4049
3. D. Boden, O. Pusch, F. Lee, L. Tucker, and B. Ramratnam Human immunodeficiency virus type 1 escape from RNA interference J. Virol. 77 2003 11531 11535
4. D. Boden, O. Pusch, F. Lee, L. Tucker, P.R. Shank, and B. Ramratnam Promoter choice affects the potency of HIV-1 specific RNA interference Nucleic Acids Res. 31 2003 5033 5038
5. Y. Chen, D. Du, J. Wu, C.P. Chan, Y. Tan, H.F. Kung, and M.L. He Inhibition of hepatitis B virus replication by stably expressed shRNA Biochem. Biophys. Res. Commun. 311 2003 398 404
6. P.K. Cheung, B. Wynhoven, and P.R. Harrigan 2004: which HIV-1 drug resistance mutations are common in clinical practice? AIDS Rev. 6 2004 107 116
7. G.A. Coburn, and B.R. Cullen Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference J. Virol. 76 2002 9225 9231
8. B.R. Cullen RNA interference: antiviral defense and genetic tool Nat. Immunol. 3 2002 597 599
9. A.T. Das, T.R. Brummelkamp, E.M. Westerhout, M. Vink, M. Madiredjo, R. Bernards, and B. Berkhout Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition J. Virol. 78 2004 2601 2605
10. R.S. Dave, and R.J. Pomerantz Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains J. Virol. 78 2004 13687 13696
11. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
12. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
13. S.D. Frost, M. Nijhuis, R. Schuurman, C.A. Boucher, and A.J. Brown Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection J. Virol. 74 2000 6262 6268
14. L. Gitlin, J.K. Stone, and R. Andino Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches J. Virol. 79 2005 1027 1035
15. F.L. Graham, and A.J. van der Eb A new technique for the assay of infectivity of human adenovirus 5 DNA Virology 52 1973 456 467
16. P.C. Haasnoot, D. Cupac, and B. Berkhout Inhibition of virus replication by RNA interference J. Biomed. Sci. 10 2003 607 616
17. J. Ji, M. Wernli, T. Klimkait, and P. Erb Enhanced gene silencing by the application of multiple specific small interfering RNAs FEBS Lett. 552 2003 247 252
18. G. Kaerber Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche Naunyn Schmiedbergs Arch. Exp. Pathol. Pharmakol. 162 1931 480 483
19. M.-T.M. Lee, G.A. Coburn, M.O. McClure, and B.R. Cullen Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector J. Virol. 77 2003 11964 11972
20. Z. Liang, Y. Yoon, J. Votaw, M.M. Goodman, L. Williams, and H. Shim Silencing of CXCR4 blocks breast cancer metastasis Cancer Res. 65 2005 967 971
21. J.A. McKeating, A. McKnight, and J.P. Moore Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization J. Virol. 65 1991 852 860
22. K.J. Metzner, S. Bonhoeffer, M. Fischer, R. Karanicolas, K. Allers, B. Joos, R. Weber, B. Hirschel, L.G. Kostrikis, and H.F. Gunthard Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions J. Infect. Dis. 188 2003 1433 1443
23. D.V. Morrissey, J.A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, W. Breen, K. Hartsough, L. Machemer, S. Radka, V. Jadhav, N. Vaish, S. Zinnen, C. Vargeese, K. Bowman, C.S. Shaffer, L.B. Jeffs, A. Judge, I. MacLachlan, and B. Polisky Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs Nat. Biotechnol. 23 2005 1002 1007
24. C.D. Novina, and P.A. Sharp The RNAi revolution Nature 430 2004 161 164
25. F.J. Palella Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman, and S.D. Holmberg Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N. Engl. J. Med. 338 1998 853 860
26. O. Pusch, D. Boden, R. Silbermann, F. Lee, L. Tucker, and B. Ramratnam Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA Nucleic Acids Res. 31 2003 6444 6449
27. S. Schubert, H.P. Grunert, H. Zeichhardt, D. Werk, V.A. Erdmann, and J. Kurreck Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs J. Mol. Biol. 346 2005 457 465
28. J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, M. John, V. Kesavan, G. Lavine, R.K. Pandey, T. Racie, K.G. Rajeev, I. Rohl, I. Toudjarska, G. Wang, S. Wuschko, D. Bumcrot, V. Koteliansky, S. Limmer, M. Manoharan, and H.P. Vornlocher Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 432 2004 173 178
29. M. Tisdale, S.D. Kemp, N.R. Parry, and B.A. Larder Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase Proc. Natl. Acad. Sci. U.S.A. 90 1993 5653 5656
30. M.A. Wainberg, W.C. Drosopoulos, H. Salomon, M. Hsu, G. Borkow, M. Parniak, Z. Gu, Q. Song, J. Manne, S. Islam, G. Castriota, and V.R. Prasad Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase Science 271 1996 1282 1285
31. E.M. Westerhout, M. Ooms, M. Vink, A.T. Das, and B. Berkhout HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome Nucleic Acids Res. 33 2005 796 804